Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.
Lalvani A, Moris P, Voss G, Pathan AA, Kester KE, Brookes R, Lee E, Koutsoukos M, Plebanski M, Delchambre M, Flanagan KL, Carton C, Slaoui M, Van Hoecke C, Ballou WR, Hill AV, Cohen J.
Lalvani A, et al. Among authors: van hoecke c.
J Infect Dis. 1999 Nov;180(5):1656-64. doi: 10.1086/315074.
J Infect Dis. 1999.
PMID: 10515829
Clinical Trial.